Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Device Debuts: Tryton, Myriad Genetics, Integra Lifesciences, Acelity, And Toyota

Executive Summary

This edition of device debuts highlights a wide variety of innovative devices introduced into commercial markets since the beginning of March, including a new stent for side-branch coronary interventions, an assay that identifies which breast-cancer patients do not need chemotherapy, a full ankle prosthesis, improvements to a negative-pressure wound therapy system, and a robotic system that helps paralyzed people learn to walk again.

Advertisement

Related Content

Integra Thinks High Margin, Differentiated Portfolio Can Deliver A Transformative 2017
US Approvals Analysis: Strong Month For IVD De Novos In February
Genomic Health Gets KO'd By Next-Gen Long-Term Breast Cancer Assays
Tornier Toes FTC Line With Lower-Extremity Sale To Integra

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel